Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy

NCT00381719 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT00381719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00381719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy
Lead sponsor
Allergan
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2006
Completion date
November 30, 2007
Enrollment
330 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic neuropathy, painful